Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
The U.S. Food and Drug Administration has banned drug imports from an India manufacturing unit of Emcure Pharmaceuticals Ltd over violations of standard manufacturing practices, the latest in a series of Indian firms to face such action.
In normal plants, a defense hormone that keeps bad bacteria out from the surface as well as inside the plant's roots and actively recruits the good ones has been detected by researchers. For the study, the researcher team introduced 38 strains of bacteria that they had isolated from roots grown in the wild soil into a sterile clay. The researchers showed that when they grew plants in that synthetic soil, the presence of salicylic acid determined which microbes colonized the roots. The findings are published in the Science Express.
IOL Chemicals and Pharmaceuticals has received US FDA approval for marketing APIs in US after successful inspection of its ibuprofen manufacturing facility situated at Barnala in Punjab. The said facility at Barnala has also been approved by ANVISA Brazil, WHO and MOH Japan. These approvals will help to build and sustaining the growth by its API business in coming years.
Scientists have discovered thousands of toxins hidden deep within the venom of a sea cone snail in Queensland, which may help develop new drugs to treat pain, cancer and other diseases. Researchers used biochemical and bioinformatics tools to develop a new method to analyse the structure of the venom toxins, allowing them to delve deeper than ever before.
(Business Wire India); Biocon Ltd, Asia's premier biopharmaceuticals company, announced today that it has delivered a strong consolidated financial performance for Q1 FY16.
GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine MosquirixTM, also known as RTS,S, in children aged 6 weeks to 17 months. Following this decision, the World Health Organization (WHO) will now formulate a policy recommendation on use of the vaccine in national immunisation programmes once approved by national regulatory authorities.
Trivitron Healthcare has added two new products in the newborn screening kit for India. The two new tests are Neonatal IRT and Neonatal Toxoplasma gondii IgM that detect disorders which may harm the newborn in later stages of life. Neonatal IRT can detect disorders affecting the lungs, pancreas, intestine and liver. Whereas, Neonatal Toxoplasma gondii IgM can detect neurological and visual disabilities.
Researchers develop a tiny wireless device that, once implanted in the brain, can be activated by remote control to deliver targeted drugs. Size of device is of the width of a human hair. It may be used to treat pain, depression, epilepsy and other neurological disorders in people by targeting therapies to specific brain areas. The researchers believe that similar, more flexible devices could have applications in other areas of the body too, including peripheral organs. The study is published in the Cell.
[adsense:336x280:8701650588]
Novartis, the world's second largest pharmaceutical company, has announced that its antimalarial medicine Coartem 80/480mg received World Health Organisation (WHO) prequalification, making it the first and only high strength (80/480mg) artemisinin-based combination therapy (ACT) antimalarial treatment available for public sector procurement. This new dosage strength has the potential to improve malaria management.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
